Composition of Other Balance Sheet Items (Tables)

12 Months Ended

Dec. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of inventories

Inventories consist of the following (dollars in thousands):

	December 31, 2023		December 31, 2022
Raw materials	$	16,274	$	24,820
Work in process	31,212		31,710
Finished goods	29,922		35,011
Total	$	77,408	$	91,541

Schedule of property and equipment

Property and equipment consist of the following (dollars in thousands):

	December 31, 2023		December 31, 2022
Lab equipment and furniture	$	13,069	$	12,127
Leasehold improvements	14,023		14,023
Software	883		883
Computer equipment	960		983
Construction-in-progress	—		206
	28,935		28,222
Less accumulated depreciation and amortization	(15,405)		(13,049)
Total	$	13,530	$	15,173

Schedule of accounts payable and accrued liabilities

Accounts payable and accrued liabilities consist of the following (dollars in thousands):

	December 31, 2023		December 31, 2022
Accounts payable	$	1,964	$	10,543
Accrued compensation, benefits, & related accruals	20,722		16,963
Accrued manufacturing expenses	11,652		15,216
Accrued sales & marketing	11,666		16,783
Accrued R&D expenses	10,530		7,490
Operating lease liabilities, current portion (1)	8,331		6,791
Accrued royalties (2)	7,918		12,022
Other accrued expenses	6,786		10,534
Total	$	79,569	$	96,342

(1) Refer to Note 12, Leases.

(2) Refer to Note 15, Commitments and Contingencies.

Schedule of accrued sales deductions

Accrued product returns and rebates consist of the following (dollars in thousands):

	December 31, 2023		December 31, 2022
Accrued product rebates	$	96,984	$	106,657
Accrued product returns	57,290		45,008
Total	$	154,274	$	151,665